Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining ...
GlobalData on MSN7h
FDA approves Amgen’s combo therapy for colorectal cancerAmgen’s LUMAKRAS (sotorasib) and Vectibix (panitumumab) combination has received approval from the US Food and Drug ...
In the CodeBreaK 300 trial, sotorasib and panitumumab had better response rates and improved PFS vs standard-of-care ...
Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday ...
On Wednesday, the Food and Drug Administration revoked authorization for the use of red dye No. 3 in food and ingested drugs.
A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...
The colorant was banned from cosmetics and non-oral medications years ago because a study showed it caused cancer in rats.
The Trump administration has promised an overhaul of various government agencies. What will happen to the Health Department?
Following the U.S. Food and Drug Administration's (FDA) order banning the use of Red Dye No. 3 in food products, Illinois ...
The decision came after years of scrutiny and debate over the safety of Red No. 3, particularly concerning its potential ...
Georgia officials halted all in-state poultry sales, and the U.S. Department of Health and Human Services awarded $590 ...
Made from petroleum and chemically known as erythrosine, red dye No. 3 is a synthetic color additive used to give foods and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback